Search results
Aug 31, 2022 · Additional awards target glioblastoma in children and young adults and breast cancer. LOS ANGELES – [August 31, 2022] – Stand Up To Cancer® (SU2C) today announced three new teams, including a Lung Cancer Health Equity SU2C Catalyst® Research Team with support from Bristol Myers Squibb; and two SU2C Catalyst® Research Teams with support from Jazz Pharmaceuticals investigating new ...
Stand Up To Cancer’s Health Equity Initiative aims to improve disparities in cancer research, screening and treatment. Communities of diverse race and ethnicity, as well as people living in rural communities, are frequently underserved by the health care system. This can result in poorer health outcomes, which is the case with cancer much too ...
Mar 5, 2020 · PHILADELPHIA — The Pancreatic Cancer Collective, the strategic partnership of Lustgarten Foundation and Stand Up To Cancer (SU2C), has awarded additional funding of up to $16 million to four teams of top researchers as part of its “New Therapies Challenge Grants,” the American Association for Cancer Research (AACR), Scientific Partner of SU2C, announced today.
The show will bring together an array of brilliant faces and much-loved stars, including all prepared to be lovingly roasted in aid of Stand Up To Cancer. This very special night will then culminate in Sean Lock: Lockipedia – a reminder of the much-missed comedy genius of one of Channel 4’s best known comics.
Stand Up To Cancer enables scientific breakthroughs by funding collaborative, multidisciplinary, multi-institutional scientific cancer research teams and investigators. Thanks to the support of our dedicated partners and the entertainment community, SU2C is able to bring widespread attention to cancer research and treatments. Visit What We Do
Aug 19, 2023 · Since launching in 2008, Stand Up To Cancer has funded innovative cancer research to help make every cancer patient a long-term survivor. We have funded over 3,000 scientists at more than 210 institutions and contributed to nine FDA approvals for new cancer therapies to end cancer’s reign as a leading cause of death.
Jan 27, 2020 · In addition, Stand Up To Cancer announced plans to fund up to $6.4MM for the SU2C Health Equity Breakthrough Research Team researching cancers affecting underrepresented populations, supported by a transformational grant from Genentech, a member of the Roche Group.
